An excess of testicular germ cell tumors in down's syndrome three case reports and a review of the literature

Cancer

Volumn 80, Issue 5, 1997, Pages 929-935

  Satgé, Daniel ^a,g   Sasco, Annie J ^b,f   Curé, Hervé ^c   Leduc, Bernard ^a   Sommelet, Danielle ^d   Vekemans, Michel J ^e  

^a CENTRE HOSPITALIER   (France)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c CENTRE JEAN PERRIN   (France)

^d HÔPITAL D ENFANTS   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f INSERM   (France)

^g Centre Hospittalier   (France)

Author keywords

Cryptorchidism; Down's syndrome; ETS 2 gene; Germ cell tumor; Gonad otropins; Testicular cancer; Trisomy 21

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE;

ADULT; ARTICLE; CASE REPORT; CRYPTORCHISM; DOWN SYNDROME; EMBRYONAL CARCINOMA; FETUS; GENE EXPRESSION; GERM CELL TUMOR; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SEMINOMA; TESTIS CARCINOMA; TRISOMY 21;

EID: 0030838538     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970901)80:5<929::AID-CNCR14>3.3.CO;2-E     Document Type: Article

References (56)

1. Heimdal K, Fossa SD. Genetic factors in malignant germcell tumors. World J Urol 1994;12:178-81.
2. Rajpert-de Meyts E, Skakkebaek NE. The possible role of sex hormones in the development of testicular cancer. Eur Urol 1993;23:54-61.
3. Strohmeyer T. Molecular biologic investigations of protooncogenes and growth factors in human testicular tumors. World J Urol 1994;12:74-8.
4. Parkin DM, Muir CS, Whelan SL, Gao Y-T, Ferlay J, Powell J, editors. Testis (ICD-9 186). In: Cancer incidence in five continents. Volume VI. IARC Sci Pub. Lyon: IARC, 1992:972-3.
5. Holland WW, Doll R, Carter CO. The mortality from leukaemia and other cancers among patients with Down's syndrome (Mongols) and among their parents. Br J Cancer 1962;16:177-86.
6. Matsaniotis N, Karpouzas J, Economou-Mavrou C. Hypothyroidism and seminoma in association with Down's syndrome. J Pediatr 1967;70:810-2.
7. Jackson EW, Turner JH, Klauber MR, Norris FD. Down's's syndrome: variation of leukemia occurrence in institutionalized populations. J Chron Dis 1968;21:247-53.
8. Li FP, Fraumeni JF Jr. Testicular cancers in children: epidemiologic characteristics. J Natl Cancer Inst 1972;48:1575-81.
9. Deaton JG. The mortality rate and causes of death among institutionalised mongols in Texas. J Ment Defic Res 1973: 17:117-22.
10. Buffé D. Fetoproteins and children's tumors. GANN Monog Cancer Res 1973;14:117-28.
11. Oster J, Mikkelsen M, Nielsen A. Mortality and life-table in Down's's syndrome. Acta Paediatr Scand 1975;64:322-6.
12. Sakashita S, Koyanagi T, Tsuji I, Arikado K, Matsuno T. Congenital anomalies in children with testicular germ cell tumor. J Urol 1980;124:889-91.
13. Kamidono S, Takada K, Ishigami J, Furumoto M, Urano Y. Giant seminoma of undescended testis in Down syndrome. Urology 1985;25:637-40.
14. Braun DL, Green MD, Rausen AR, David R, Wolman SR, Greco MA, et al. Down's syndrome and testicular cancer: a possible association. Am J Pediatr Hematol Oncol 1985; 7:208-11.
15. Fukushima Y, Kuroki Y. Clinical findings. In: Baba K, Kobayashi N, editors. Down's syndrome. Pediatric Mook. Tokyo: Kanahara Press, 1985:1-17.
16. Sasagawa I, Kazama T, Umeda K, Kohno T, Katayama T, Miwa A. Down's syndrome associated with seminoma. Urol Int 1986;41:238-40.
17. Sasagawa I, Nakada T, Hashimoto T, Ishigooka M, Izumiya K, Kubota Y, et al. Hormone profiles and contralateral testicular histology in Down's syndrome with unilateral testicular tumor. Arch Androl 1993;30:93-8.
18. Dexeus FH, Logothetis CJ, Chong C, Sella A, Ogden S. Genetic abnormalities in men with germ cell tumors. J Urol 1988;140:80-4.
19. Mann JR, Pearson D, Barrett A, Raafat F, Barnes JM, Wallendszus KR. Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies. Cancer 1989;63:1657-67.
20. Frey P, Fliegel C, Herzog B. Testicular tumours in infancy and childhood. A review of 10 germ cell tumours and 10 non germ cell tumours. Z Kinderchir 1990;45:229-34.
21. Narod SA, Stiller C, Lenoir GM. An estimate of the heritable fraction of childhood cancer. Br J Cancer 1991;63:993-9.
22. Jacobsen GK, Henriques UV. A fetal testis with intratubular germ cell neoplasia (ITGCN). Mod Pathol 1992;5:547-9.
23. Hashimoto T., Sasagawa I, Ishigooka M, Kubota Y, Nakada T, Fujita T, et al. Down's syndrome associated with intracranial germinoma and testicular embryonal carcinoma. Ural Int 1995;55:120-2.
24. Sleijfer S, Schraffordt Koops H, van der Graaf WTA. Sucessful treatment on an out-patient basis of a patient with Down's syndrome and disseminated testicular seminoma. Neth J Med 1996;48:89-91.
25. Satgé D, Jacobsen GK, Cessot F, Raffi F, Vekemans M. A fetus with Down syndrome and intratubular germ cell neoplasia. Pediatr Pathol Lab Med 1996;16:107-12.
26. Perry C, Servadio C. Seminoma in childhood. J Urol 1980;124:932-3.
27. Satgé D, Sommelet D, Geneix A, Malet P, Vekemans M. Tumoral profile in Down syndrome: a step towards the understanding of the consequences of aneuploidy and the development of cancer. Am J Hum Genet 1994;55 (Suppl A):303.
28. Powers LW, Register MK. Down's syndrome and acute leukemia: epidemiological and genetic relationships. Laboratory Medicine 1991;22:630-6.
29. Scholl T, Stein Z, Hansen H. Leukemia and other cancers, anomalies and infections as causes of death in Down's syndrome in the United States during 1976. Dev Med Child Neural 1982;24:817-29.
30. Satgé D, Le Tourneau A, Verger JP, Lefort S, Geneix A, Malet P, et al. A case report of Down's syndrome and centroblastic lymphoma. Pathol Res Pract 1996;192:1266-9.
31. Satgé D, Sasco AJ, Carlsen NLT, Rubie H, Stiller CA. A negative association between Down's syndrome and neuroblastoma. Arch Dis Child 1997;67:80.
32. Olson JM, Hamilton A, Breslow NE. Non -11p constitutional chromosome abnormalities in Wilms' tumor patients. Med Pediatr Oncol 1995;24:305-9.
33. Jancar MP, Jancar J. Cancer and mental retardation. Bristol Med Chir J 1976;92:3-7.
34. Lejeune J, Gautier M, Turpin R. Etude des chromosomes somatiques de neuf enfants mongoliens. C R Acad Sci III 1959;248:1721-2.
35. Castedo SMMJ, de Jong B, Oosterhuis JW, Seruca R, Buist J, Schraffordt Koops H. Cytogenetic study of a combined germ cell tumor of the testis. Cancer Genet Cytogenet 1988;35:159-65.
36. Vos AM, Oosterhuis JW, de Jong B, Buist J, Schraffordt Koops H. Cytogenetics of carcinoma in situ of the testis. Cancer Genet Cytogenet 1990;46:75-81.
37. Rodriguez E, Mathew S, Mukherjee AB, Reuter VE, Bosl GJ, Chaganti RSK. Analysis of chromosome 12 aneuploidy in interphase cells from human male germ cell tumors by fluorescence in situ hybridization. Genes Chromosom Cancer 1992;5:21-9.
38. Van Echten J, Oosterhuis JW, Looijenga LHJ, van de Pol M, Wiersema J, te Meerman GJ, et al. No recurrent structural abnormalities apart from i(12p) in primary germ cell tumors of the adult testis. Genes Chromosom Cancer 1995;14:133-44.
39. Benson RC, Beard CM, Kelalis PP, Kurland LT. Malignant potential of the cryptorchid testis. Mayo Clin Proc 1991; 66:372-8.
40. Jones KL. Down syndrome. In: Smith's recognizable patterns of human malformations. 4th edition. Philadelphia: W.B. Saunders Company, 1988:10-5.
41. Dirix LY, Wouters E, van Nueten J, van Eerdeweg W, van Oosterom AT. Cryptorchidism and extragonadal germ cell tumor. Urol Int 1995;55:44-5.
42. Forman D, Pike MC, Davey G, Dawson S, Baker K, Chilvers CED, et al. Aetiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility and exercise. BMJ 1994;308:1393-9.
43. Johnson DE, Woodhead DM, Pohl DR, Robison JR. Cryptorchism and testicular tumorigenesis. Surgery 1968;63:919-22.
44. Augé B, Satgé D, Sauvage P, Lutz P, Chenard MP, Levy JM. Les tératomes rétropéritonéaux de la période périnatale. Revue de la littérature à propos d'un tératome néonatal immature agressif. Ann Pédiat 1993;40:613-21.
45. Oshita N, Yamashita K, Gotou K, Nagata I, Ueda H, Mitani T. A case of endodermal sinus tumor in the basal ganglia associated with Down's syndrome. No Shinkei Geka 1993;21:345-9.
46. Hasen J, Boyar RM, Shapiro LR. Gonadal function in trisomy 21. Horm Res 1980;12:345-50,
47. Hestnes A, Stovner LJ, Husoy O, Folling I, Fougner KJ, Sjaastad O. Hormonal and biochemical disturbances in Down's syndrome. J Mental Def Res 1991;35:179-93.
48. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Canick JA, Haddow JE, et al. Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome. Br J Obstet Gynaecol 1988;95:334-41.
49. Hansen PV, Trykker H, Andersen J, Helkjaer PE. Germ cell function and hormonal status in patients with testicular cancer. Cancer 1989;64:956-61.
50. Hoff Wanderas E, Fossa SD, Heilo A, Stenwig AE, Norman N. Serum follicle stimulating hormone-predictor of cancer in the remaining testis in patients with unilateral testicular cancer. Br J Urol 1990;66:315-7.
51. Epstein CJ. Specificity versus nonspecificity in the pathogenesis of aneuploid phenotypes. Am J Med Genet 1988;29:161-5.
52. Drabkin HA, Erickson P. Down's syndrome and leukemia, an update. In: Epstein CJ, Hassold T, Lott IT, Nadel L, Patterson D, editors. Etiology and pathogenesis of Down's syndrome. Progress in clinical and biological research. Volume 393. New York: Wiley-Liss, 1995:169-76.
53. Maroulakou IG, Papas TS, Green JE. Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis. Oncogene 1994;9:1551-65.
54. Hromas R, Klemsz M. The ETS oncogene family in development, proliferation and neoplasia. Int J Hematol 1994; 59:257-65.
55. Bhat NK, Fisher RJ, Fujiwara S, Ascione R, Papas TS. Temporal and tissue-specific expression of mouse ets genes. Proc Natl Acad Sci USA 1987;84:3161-5.
56. Davies PO, Willison KR. Molecular mechanisms of differentiation in mammalian spermatogenesis. Dev Biol 1993;3:179-88.